PQRI Work Project Concept Fundamental Understanding of Sulfonate Ester-Forming Reactions April 2006.

Slides:



Advertisements
Similar presentations
Performance Assessment
Advertisements

The Regulatory Impact Analysis Statement (RIAS) in Canada
Post Research Benefits Mandika Wijeyaratne MS, MD, FRCS Dept. of Surgery, Colombo.
Ambition in Action. Ambition in Action Preparing and Presenting an Effective Business Case Presentation to HIMAA July 2010.
GSE Annual Conference Breakout Session: Leadership and Skills.
PROJECT RISK MANAGEMENT
PROJECT TITLE Project Leader: Team: Executive Project Sponsor (As Required): Date: Month/Day/Year 110/17/2014 V1.
PROJECT TITLE Project Leader: Team: Executive Project Sponsor (As Required): Date: Month/Day/Year 110/17/2014 V1.
ICH Q11 – Definisjon av startmaterialer – Fleksibilitet og dokumentasjonskrav Andreas Sundgren LMI 17. april 2012.
IDBM industry project Project Plan. Add text here giving a brief background of the project Project Background.
Integrating CMC Review & Inspection Industry Recommendations Joe Anisko April 24, 2003.
Understanding Research Articles Microbiology Laboratory.
Choosing and Defining a Research Problem Dr. U N Roy Associate Professor, NITTTR Chandigarh Mobile No: Dr U N Roy.
PPA 502 – Program Evaluation
1 Template Guidelines This presentation is to be used as a template to create your LDRD presentation. The presentation and question/answer period are limited.
Senior Review Evaluations (1 of 5) Proposals due: 6 March 2015 Panel evaluations: Week of 22 April 2015 Performance factors to be evaluated will include.
Community Planning Training 1-1. Community Plan Implementation Training 1- Community Planning Training 1-3.
INCOSE 1 st reactions. One other area that struck me has the sheer number of levels of proficiency—in ours we are going with 5 and the first one is limited.
Developing Enterprise Architecture
Creating the relationship between good science and informed policy John C. Tracy, Director Idaho Water Resources Research Institute University of Idaho.
Strengthening the quality of research for policy engagement in the African context – achievements and aspirations Tebogo B. Seleka Botswana Institute for.
Clinical Research Training
1 Module 4: Designing Performance Indicators for Environmental Compliance and Enforcement Programs.
Parliamentary Committees in Democracies: Unit 4 Research Services for Parliamentary Committees.
Training of Process Facilitators Training of Process Facilitators.
Professional Certificate – Managing Public Accounts Committees Ian “Ren” Rennie.
Policy Considerations in the Lower Poplar River Turbidity TMDL Study Greg Johnson, Karen Evens, and Pat Carey, Minnesota Pollution Control Agency, St.
Ajaz S. Hussain, Ph.D. Deputy Director Office of Pharmaceutical Science, CDER, FDA ACPS Subcommittee on Manufacturing Science: Identification and Prioritization.
1 Introduction to Evaluating the Minnesota Demonstration Program Paint Product Stewardship Initiative September 19, 2007 Seattle, WA Matt Keene, Evaluation.
Fundamentals of Evaluation for Public Health Programs ROBERT FOLEY, M.ED. NIHB TRIBAL PUBLIC HEALTH SUMMIT MARCH 31,
Chapter 6 : Software Metrics
The AIACC Project Assessments of Impacts and Adaptations to Climate Change in Multiple Regions & Sectors UNFCCC Workshop Bonn 9 June 2003.
Research Project Grant (RPG) Retreat K-Series March 2012 Bioengineering Classroom.
1 Commissioned by PAMSA and German Technical Co-Operation National Certificate in Paper & Pulp Manufacturing NQF Level 4 Perform visual inspection tests.
Product Documentation Chapter 5. Required Medical Device Documentation  Business proposal  Product specification  Design specification  Software.
Overview EvaluationProcessIntroduction Conclusion Tasks Standards.
Technology Transfer Execution Framework. 2 © 2007 Electric Power Research Institute, Inc. All rights reserved. Relationship Between Your EPRI Value and.
Scientific Merit Review René St-Arnaud, Ph.D. Shriners Hospital and McGill University CCAC National Workshop May 13, 2010, Ottawa (Ontario)
BCO Impact Assessment Component 3 Scoping Study David Souter.
World Intellectual Property Organization DCPPS 1 presented by Mr. Vladimir Yossifov WIPO NATIONAL WORKSHOP ON INNOVATION SUPPORT SERVICES AND THEIR MANAGEMENT.
1 Click to edit Master text styles Second level Third level Fourth level Fifth level Administrative Support for Large- Scale Funding Applications – Session.
Risk-Based CMC Review - OGD Perspective Gary J. Buehler, R.Ph. Director Office of Generic Drugs July 21, 2004 Advisory Committee for Pharmaceutical Science.
Abstract The purpose of this presentation is to summarize the literature related to the utilization of organizational consultation to produce systems-level.
COMPARABILITY PROTOCOLUPDATE ADVISORY COMMITTEE FOR PHARMACEUTICAL SCIENCE Manufacturing Subcommittee July 20-21, 2004 Stephen Moore, Ph.D. Chemistry Team.
PQRI Proposed Work Plan Title of Work Project Date of Submission to Steering Committee.
DEFENSE THREAT REDUCTION AGENCY JOINT SCIENCE AND TECHNOLOGY OFFICE CHEMICAL AND BIOLOGICAL DEFENSE create collaborate communicate Click to add title of.
Atlantic Innovation Fund Round VIII February 5, 2008.
WP3 Harmonization & Integration J. Lauterjung & WP 3 Group.
1 Nanoscale Materials Stewardship Program Environmental Summit May 20, 2008 Jim Alwood Chemical Control Division Office of Pollution Prevention and Toxics.
1 InSAR Project Information. 2 Outline Purpose Two components – SAR investigation, InSAR study SAR investigation: presentation only InSAR study: presentation.
PQRI Work Project Concept Title of Work Project Date of Submission.
Fundamentals of Governance: Parliament and Government Understanding and Demonstrating Assessment Criteria Facilitator: Tony Cash.
PQRI Project Update Title of Work Project Date of Submission.
National Public Health Institute, Finland Open Risk Assessment Lecture 2: General assessment framework Mikko Pohjola KTL, Finland.
HERA Second European Stakeholder Workshop July Human & Environmental Risk Assessment An A.I.S.E and CEFIC initiative on targeted risk assessment.
Session 2: Developing a Comprehensive M&E Work Plan.
Health and Food Safety EU strategy for Pharmaceuticals in the Environment Patrizia Tosetti DG SANTE European Commission China/EU Pharmaceutical Industry.
NIH Change Management Program Change Management Program Overview March 8,
EIAScreening6(Gajaseni, 2007)1 II. Scoping. EIAScreening6(Gajaseni, 2007)2 Scoping Definition: is a process of interaction between the interested public,
New Ecological Science Advice for Ecosystem Protection The EPA Science Advisory Board (SAB) Staff Office supports three external scientific advisory committees.
Objective: Develop hybrid biological semiconductors which are EMP resistant and whose electronic properties can be directly manipulated by environmental.
Short Contribution Title Goes Here
Also called Objectives
Template Guidelines Please use this template to create your LDRD presentation- we highly recommend that you address all aspects of the proposal as outlined.
RISK ASSESSMENT TOOL PREVIEW
PQRI Project Update Fundamental Understanding of Sulfonate Ester-Forming Reactions Date of Original Submission: April 2006 Date of Current Report: February.
Research Project Grant (RPG) Retreat R-series
Short Contribution Title Goes Here
Safety Analytics Workshop – Computational Science Symposium 2019
NEED: What need does your project address?
Presentation transcript:

PQRI Work Project Concept Fundamental Understanding of Sulfonate Ester-Forming Reactions April 2006

Objective of Work Project Description of overall objective of work project What are the challenges (issues with product quality) the project (deliverable) is intended to address? Is this problem worth solving and if so, Why? Definition of key stakeholders (i.e., what is the target audience; who will be interested in the results?)

Background of Work Project Concern exists that sulfonate esters may be genotoxic impurities and are potentially formed during drug substance manufacturing when sulfonic acids are used in the presence alcoholic solvents The elimination of sulfonic acids from drug substance manufacturing would be highly undesirable due to its useful synthetic properties – This is a potential regulatory outcome if the issue is not addressed The amount of sulfonate esters formed under synthetically relevant conditions is currently unclear

Objective of Work Project To scientifically demonstrate that sulfonic acids can safely be used in drug substance manufacturing by – Understanding the kinetics of formation and decomposition of sulfonate esters during drug substance manufacture under synthetically relevant conditions – Demonstrating that conditions can be manipulated to control the levels of sulfonate esters formed

Key Stakeholders Global regulatory agencies – The question of potentially genotoxic impurities is of significant concern to them, this adds to the body of available knowledge and allows them to use science to make better decisions Pharmaceutical manufacturers – Data on impurity formation would allow the possibility of a scientific discussion with regulators on required controls and support continued use of sulfonic acids – Would also provide useful synthetic knowledge to allow minimization of the formation of sulfonate esters

Key Deliverables and Outcomes Definition of key deliverables and approximate timeline required to achieve each deliverable – Method development (timing depends on difficulties encountered) – Experimental protocol design – Execution of experiments to demonstrate impact of synthetic parameters on formation of sulfonate esters – Final output available in March of 2009 What are the potential risks involved with the project? – Data collected is not valuable in answering the question – Considered to be highly unlikely, i.e. project should have a meaningful outcome

Impact of Work Project If this project is successful, what would be the impact on product quality? – Data would be available that would demonstrate how the formation of sulfonate esters can be controlled and thus allow the continued use of sulfonic acids in synthesis – Discussion with regulators on controls necessary to mitigate the risk of sulfonate esters, including specifications, can be based on science

Communication of Work Project Description of intent of external communication (e.g., to provide best practice, to influence regulatory policy, etc.) – To influence regulatory expectations, as described earlier Description of internal and external communication plan (e.g., white paper, published article, workshop, etc.) – It is expected that several technical papers in peer-reviewed journals will be published

Funding Requirements It is estimated that somewhere between 100K and 300K will be required to fund this project through to completion (spread over about 2 years) – It is anticipated that a contract lab will be hired to perform the method development and subsequent experiments – It may be necessary to hire a project manager – Funds will be needed from PQRI but there is a possibility that member organizations will partially fund due to high interest level

Skill/Knowledge Set Define the skills/knowledge sets necessary to complete the work project – Synthetic and analytical chemists Outline the plan for obtaining necessary skills (e.g., contract with external expert, utilize member organization expertise, etc.) – May be a combination of internal and external expertise; plan to investigate possibility of contract lab and project manager